Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications
- 1 July 1979
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 98 (1), 119-131
- https://doi.org/10.1016/0002-8703(79)90327-2
Abstract
No abstract availableThis publication has 87 references indexed in Scilit:
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic propertiesAmerican Heart Journal, 1979
- ALPRENOLOL AND PROPRANOLOL IN THE TREATMENT OF HYPERTENSION: A COMPARATIVE STUDYActa Medica Scandinavica, 1974
- Use of ??-Adrenergic Receptor Blocking Drugs in PsychiatryDrugs, 1974
- Antihypertensive and Hemodynamic Properties of the New Beta Adrenergic Blocking Agent TimololCirculation, 1973
- Control of persistent ventricular ectopic beats by alprenolol, a new beta-adrenergic blocking agentAmerican Heart Journal, 1969
- Propranolol in persistent ventricular fibrillation complicating acute myocardial infarctionAmerican Heart Journal, 1968
- Ineffectiveness of propranolol in hypertensive Jamaicans.BMJ, 1968
- Beta-adrenergic blockade in patients with hypertrophic obstructive cardiomyopathyAmerican Heart Journal, 1967
- Beta-Adrenergic Blockade in the Treatment of Exercise-Induced Paroxysmal Ventricular TachycardiaCirculation, 1965
- The Hemodynamic and Metabolic Interrelationships in the Activity of Epinephrine, Norepinephrine and the Thyroid HormonesCirculation, 1956